Biotie Therapies Revenue, Profits - BITI Quarterly Income Statement

Add to My Stocks
$25.8 $0.71 (2.68%) BITI stock closing price Jun 10, 2016 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Biotie Therapies stock price alone is not sufficient. In the income statement, an investor can check for important parameters like the topline or sales, the bottomline or profits, the basic EPS, dividends etc. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $- for 2016 Q1 impacts the BITI stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Biotie Therapies assets and Biotie Therapies free cash flow, Biotie Therapies profits as shown in profit and loss statement give key insights about the business. The net profit for 2016 Q1 is $-12.88M and the 2016 Q1 revenue is $-.

View and download details of revenue and profits for Biotie Therapies for latest & last 40 quarters.
show more
Fiscal year is Jan - Dec2016 Q12015 Q4
Biotie Therapies Revenues or Net Sales
--
Cost Of Goods Sold (COGS)--
Biotie Therapies Gross Profit
--
Research & Development Expense6.19M6.89M
Selling General & Admin Expense5.21M1.87M
Income Before Depreciation Depletion Amortization-10.57M-7.94M
Depreciation Depletion Amortization--
Non Operating Income-2.13M2.1M
Interest Expense--
Biotie Therapies Pretax Income
-12.87M-6.02M
Provision for Income Taxes--
MinorityInterest--
Investment Gains Losses--
Other Income--
Income Before Extraordinaries & Disc Operations-12.88M-6.03M
Extraordinary Items & Discontinued Operations--
Biotie Therapies Profit/ Loss (Net Income)
-12.88M-6.03M
Average Shares used to compute Diluted EPS12.26M12.23M
Average Shares used to compute Basic EPS12.26M12.23M
Income Before Nonrecurring Items-12.88M-6.03M
Income from Nonrecurring Items--
Biotie Therapies Earnings Per Share Basic Net
-0.88-0.49
Biotie Therapies Earnings Per Share Diluted Net
-0.88-0.49
EPS Diluted Before Nonrecurring Items-0.88-0.49
Preferred Dividends Acc Pd--
Dividends Common--
Dividend Per Share Common0.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on Biotie Therapies stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that BITI stock has a topline or revenue of $- for 2016 Q1 as per this Biotie Therapies revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: Most businesses like Biotie Therapies try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called statement of revenue and expense. The BITI financials along with Biotie Therapies historical stock prices provide a lot of details about the firm.